BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 29149259)

  • 1. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database.
    Ali H; Pamarthy R; Vallabhaneni M; Sarfraz S; Ali H; Rafique H
    F1000Res; 2021; 10():529. PubMed ID: 34527218
    [No Abstract]   [Full Text] [Related]  

  • 3. US lung cancer trends by histologic type.
    Lewis DR; Check DP; Caporaso NE; Travis WD; Devesa SS
    Cancer; 2014 Sep; 120(18):2883-92. PubMed ID: 25113306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.
    Wong JR; Tucker MA; Kleinerman RA; Devesa SS
    JAMA Ophthalmol; 2014 Apr; 132(4):478-83. PubMed ID: 24577366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017.
    Montminy EM; Zhou M; Maniscalco L; Penrose H; Yen T; Patel SG; Wu XC; Karlitz JJ
    JAMA Netw Open; 2021 Nov; 4(11):e2130433. PubMed ID: 34751760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
    Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
    BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
    Islami F; DeSantis CE; Jemal A
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
    Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
    Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in esophageal cancer incidence by histology, United States, 1998-2003.
    Trivers KF; Sabatino SA; Stewart SL
    Int J Cancer; 2008 Sep; 123(6):1422-8. PubMed ID: 18546259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.
    Linares I; Molina-Portillo E; Expósito J; Baeyens JA; Suárez C; Sánchez MJ
    Clin Transl Oncol; 2016 May; 18(5):489-96. PubMed ID: 26329296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA.
    Pei X; Song F; Wang Z
    Medicine (Baltimore); 2019 Dec; 98(51):e17175. PubMed ID: 31860944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior.
    Shiels MS; Kreimer AR; Coghill AE; Darragh TM; Devesa SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1548-56. PubMed ID: 26224796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver, gallbladder, extrahepatic bile ducts, and pancreas.
    Carriaga MT; Henson DE
    Cancer; 1995 Jan; 75(1 Suppl):171-90. PubMed ID: 8000995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
    Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
    Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.
    Aschebrook-Kilfoy B; Kaplan EL; Chiu BC; Angelos P; Grogan RH
    Ann Surg Oncol; 2013 Aug; 20(8):2746-53. PubMed ID: 23504142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancers with increasing incidence trends in the United States: 1999 through 2008.
    Simard EP; Ward EM; Siegel R; Jemal A
    CA Cancer J Clin; 2012; 62(2):118-28. PubMed ID: 22281605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent cancer trends in the United States.
    Devesa SS; Blot WJ; Stone BJ; Miller BA; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 1995 Feb; 87(3):175-82. PubMed ID: 7707404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.